Sunshine Biopharma
(NASDAQ) SBFM
Sunshine Biopharma Financials at a Glance
Market Cap
$5.10M
Revenue (TTM)
$37.32M
Net Income (TTM)
$5.99M
EPS (TTM)
$-1.86
P/E Ratio
-0.56
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$1.04
Volume
20
Open
$1.08
Price
$1.04
Volume
20
Open
$1.08
Previous Close
$1.04
Daily Range
$1.04 - $1.08
52-Week Range
$1.00 - $2.43
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$1.04
Volume
20
Open
$1.08
Previous Close
$1.04
Daily Range
$1.04 - $1.08
52-Week Range
$1.00 - $2.43
SBFM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sunshine Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
50
CEO
Steve N. Slilaty, PhD
Website
www.sunshinebiopharma.comHeadquarters
Pointe-Claire, QC H9R 0A5, CA
SBFM Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
-17%
Net Income Margin
-16%
Return on Equity
-26%
Return on Capital
-26%
Return on Assets
-19%
Earnings Yield
-1.79%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.10M
Shares Outstanding
4.91M
Volume
20
Short Interest
0.00%
Avg. Volume
36.18K
Financials (TTM)
Gross Profit
$12.26M
Operating Income
$6.23M
EBITDA
$5.62M
Operating Cash Flow
$5.33M
Capital Expenditure
$0.00
Free Cash Flow
$5.33M
Cash & ST Invst.
$9.12M
Total Debt
$0.00
Sunshine Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.42M
+11.6%
Gross Profit
$3.07M
+7.2%
Gross Margin
32.64%
N/A
Market Cap
$5.10M
N/A
Market Cap/Employee
$98.12K
N/A
Employees
52
N/A
Net Income
$883.82K
+26.2%
EBITDA
$925.10K
-0.8%
Quarterly Fundamentals
Net Cash
$8.45M
-27.5%
Accounts Receivable
$4.16M
+29.1%
Inventory
$14.06M
+43.2%
Long Term Debt
$636.71K
+44.6%
Short Term Debt
$218.05K
+87.6%
Return on Assets
-19.03%
N/A
Return on Invested Capital
-26.07%
N/A
Free Cash Flow
$735.84K
+60.8%
Operating Cash Flow
$727.80K
+46.5%